Literature DB >> 17442981

Genetic stability of human T lymphotropic virus type I despite antiviral pressures by CTLs.

Ryuji Kubota1, Kousuke Hanada, Yoshitaka Furukawa, Kimiyoshi Arimura, Mitsuhiro Osame, Takashi Gojobori, Shuji Izumo.   

Abstract

Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an inflammatory neurological disease. Patients with HAM/TSP show high proviral load despite increased HTLV-I Tax-specific CTL. It is still unknown whether the CTL efficiently eliminate the virus in vivo and/or whether a naturally occurring variant virus becomes predominant by escaping from the CTL. To address these issues, we sequenced a large number of HTLV-I tax genes from HLA-A*02 HAM/TSP patients and estimated synonymous and nonsynonymous changes of the genes to detect positive selection pressure on the virus. We found the pressures in three of six CTL epitopes in HTLV-I Tax, where amino acid substitutions preferentially occurred. Although some of variant viruses were not recognized by the CTL, no variant viruses accumulated within 3-8 years, indicating genetic stability of HTLV-I tax gene. These results suggest that CTL eliminate the infected cells in vivo and naturally occurring variant viruses do not predominate. As Tax is a regulatory protein which controls viral replication, the amino acid substitutions in Tax may reduce viral fitness for replication. Viral fitness and host immune response may contribute to the viral evolution within the infected individuals. Furthermore, the genetic stability in the epitopes despite the antiviral pressures suggests that the three epitopes can be the candidate targets for HTLV-I vaccine development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17442981     DOI: 10.4049/jimmunol.178.9.5966

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.

Authors:  Reza Boostani; Rosita Vakili; Samane Sadat Hosseiny; Ali Shoeibi; Bahare Fazeli; Mohammad Mehdi Etemadi; Faeze Sabet; Narges Valizade; Seyed Abdolrahim Rezaee
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

2.  Cellular Immune Responses against Simian T-Lymphotropic Virus Type 1 Target Tax in Infected Baboons.

Authors:  Iris Castro; Teresa M Giret; Diogo M Magnani; Helen S Maxwell; Oliver Umland; Jessica K Perry; Jerilyn K Pecotte; Kathleen M Brasky; Glen N Barber; Ronald C Desrosiers; David I Watkins
Journal:  J Virol       Date:  2016-05-12       Impact factor: 5.103

3.  Simian T Lymphotropic Virus 1 Infection of Papio anubis: tax Sequence Heterogeneity and T Cell Recognition.

Authors:  James M Termini; Diogo M Magnani; Helen S Maxwell; William Lauer; Iris Castro; Jerilyn Pecotte; Glen N Barber; David I Watkins; Ronald C Desrosiers
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

4.  HLA class I binding of HBZ determines outcome in HTLV-1 infection.

Authors:  Aidan Macnamara; Aileen Rowan; Silva Hilburn; Ulrich Kadolsky; Hiroshi Fujiwara; Koichiro Suemori; Masaki Yasukawa; Graham Taylor; Charles R M Bangham; Becca Asquith
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

5.  How does HTLV-I persist despite a strong cell-mediated immune response?

Authors:  Becca Asquith; Charles R M Bangham
Journal:  Trends Immunol       Date:  2007-11-26       Impact factor: 16.687

Review 6.  HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection.

Authors:  Charles R M Bangham; Lucy B Cook; Anat Melamed
Journal:  Semin Cancer Biol       Date:  2013-12-06       Impact factor: 15.707

7.  Evolution and diversity of secretome genes in the apicomplexan parasite Theileria annulata.

Authors:  William Weir; Tülin Karagenç; Margaret Baird; Andy Tait; Brian R Shiels
Journal:  BMC Genomics       Date:  2010-01-18       Impact factor: 3.969

8.  High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response.

Authors:  Frederic Toulza; Adrian Heaps; Yuetsu Tanaka; Graham P Taylor; Charles R M Bangham
Journal:  Blood       Date:  2007-12-19       Impact factor: 22.113

9.  Therapeutic benefits of an oral vitamin B1 derivative for human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Jun-Ichi Kira
Journal:  BMC Med       Date:  2013-08-15       Impact factor: 8.775

10.  Association between HLA Class I Alleles and Proviral Load in HTLV-I Associated Myelopathy/Tropical Spastic Paraperesis (HAM/TSP) Patients in Iranian Population.

Authors:  Mahdi Taghaddosi; S A Rahim Rezaee; Houshang Rafatpanah; Taraneh Rajaei; Reza Farid Hosseini; Valizadeh Narges
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.